Focus on Patient Care With Dima Diab, MD
Focus On highlights faculty, staff, students and researchers at the UC Academic Health Center. To suggest someone to be featured, please email uchealthnews@uc.edu.
Originally from Lebanon, Dima Diab, MD, completed her bachelors degree in biology at the American University of Beirut (AUB) in 1998. She stayed at AUB to complete her medical degree, which she earned in 2002.
Diab spent one additional year in Beirut for an internal medicine internship and then came to the University of Cincinnati for a three-year internal medicine residency. She completed a fellowship in endocrinology at The Cleveland Clinical Foundation in 2008 before joining UCs faculty and University of Cincinnati Physicians.
Diab is fluent in Arabic and English and sees patients at the UC Health Physicians Office in Clifton. Appointments or referrals can be made by calling (513) 475-7400.
How long have you been with UC?
"I have been with UC since July 2008 as assistant professor of clinical medicine with the UC Division of Endocrinology, Diabetes and Metabolism.
What is your current clinical focus?
"I see general endocrinology and diabetes patients with a special focus on osteoporosis and metabolic bone diseases. (Diab is now reading bone mineral density scans (DXA scans) with the UC Bone Health and Osteoporosis Center in Clifton.)
What do you find most rewarding about caring for patients?
"Getting to know the patients and being able to make a difference not only by treating them medically, but also by supporting them personally.
What do you like to do in your spare time?
"My hobbies and interests include playing the piano, going to the theater, swimming and spending quality time with my family.
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.